We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+9.45%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$428B
AUM Growth
-$10.7B
Cap. Flow
-$22.3B
Cap. Flow %
-5.22%
Top 10 Hldgs %
27.96%
Holding
16,128
New
3,614
Increased
5,201
Reduced
5,802
Closed
1,312

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$913M
2
META icon
Meta Platforms (Facebook)
META
+$659M
3
CAT icon
Caterpillar
CAT
+$450M
4
PYPL icon
PayPal
PYPL
+$435M
5
BDX icon
Becton Dickinson
BDX
+$348M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$860M
2
HUM icon
Humana
HUM
+$581M
3
GS icon
Goldman Sachs
GS
+$372M
4
BSX icon
Boston Scientific
BSX
+$345M
5
WMT icon
Walmart Inc
WMT
+$327M

Sector Composition

Rank Sector Weight
1 Technology 3.36%
2 Healthcare 2.87%
3 Financials 2.57%
4 Consumer Discretionary 2.23%
5 Industrials 2.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYEL icon
13601
CALL
Lyell Immunopharma
LYEL
$342M
$9.37K ﹤0.01%
+135
New +$13.4K
UBX
13602
PUT
DELISTED
Unity Biotechnology
UBX
$9.34K ﹤0.01%
+3,410
New +$9.91K
XBIO icon
13603
Xenetic Biosciences
XBIO
$7.51M
$9.31K ﹤0.01%
+3,257
New +$14.3K
AKTS
13604
CALL
DELISTED
Akoustis Technologies Inc
AKTS
$9.31K ﹤0.01%
+3,300
New +$10.4K
NNBR icon
13605
PUT
NN Inc
NNBR
$322M
$9.3K ﹤0.01%
+6,200
New +$11.5K
FSS icon
13606
CALL
Federal Signal
FSS
$7.68B
$9.29K ﹤0.01%
+200
New +$9.18K
EVER icon
13607
EverQuote
EVER
$861M
$9.29K ﹤0.01%
630
-61,205
-99% -$575K
MKFG
13608
PUT
DELISTED
Markforged Holding Corporation
MKFG
$9.28K ﹤0.01%
800
-650
-45% -$9.9K
ZYNE
13609
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$9.26K ﹤0.01%
17,471
-102,364
-85% -$64.9K
MBIO icon
13610
CALL
Mustang Bio
MBIO
$4.5M
$9.24K ﹤0.01%
31
+13
+72% +$4.44K
BTBT icon
13611
Bit Digital
BTBT
$566M
$9.22K ﹤0.01%
15,371
-28,863
-65% -$26.9K
VLRS
13612
PUT
Controladora Vuela Compania de Aviacion
VLRS
$906M
$9.2K ﹤0.01%
+1,100
New +$9.76K
PGY icon
13613
PUT
Pagaya Technologies
PGY
$1.8B
$9.18K ﹤0.01%
+617
New +$8.54K
CHRN
13614
PUT
ChronoScale Holdings
CHRN
$3.04B
$9.16K ﹤0.01%
513
-1,180
-70% -$24.4K
HEPA
13615
CALL
DELISTED
Hepion Pharmaceuticals
HEPA
$9.15K ﹤0.01%
31
-17
-35% -$7.18K
IBOC icon
13616
CALL
International Bancshares
IBOC
$4.56B
$9.15K ﹤0.01%
+200
New +$9.63K
SBEV icon
13617
CALL
Splash Beverage Group
SBEV
$2.55M
$9.13K ﹤0.01%
59
-13
-18% -$2.28K
CEMI
13618
CALL
DELISTED
Chembio diagnostics, Inc.
CEMI
$9.12K ﹤0.01%
41,500
-1,600
-4% -$478
HOMB icon
13619
PUT
Home BancShares
HOMB
$6.28B
$9.12K ﹤0.01%
+400
New +$9.7K
OGEN icon
13620
Oragenics
OGEN
$2.4M
$9.11K ﹤0.01%
+48
New +$16.9K
SOND
13621
DELISTED
Sonder
SOND
$9.11K ﹤0.01%
+367
New +$13K
SVFA
13622
PUT
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$9.1K ﹤0.01%
+900
New +$9.03K
VRPX
13623
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$9.09K ﹤0.01%
+58
New +$13.2K
SCTL
13624
CALL
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$9.09K ﹤0.01%
6,100
-120,200
-95% -$189K
LFLY
13625
PUT
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
$9.06K ﹤0.01%
695
-3,025
-81% -$44.1K

Similar funds

Ken Griffin's Q4 2022 Portfolio in Review

As of Q4 2022, Ken Griffin held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ken Griffin opened a new position in Denbury Inc. worth $107M.

  • Ken Griffin's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
  • Ken Griffin added most to Tesla in Q4 2022, an estimated $913M increase.
  • Ken Griffin's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
  • Ken Griffin fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
  • Ken Griffin's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
  • Ken Griffin opened 3,614 new positions and closed 1,312 in Q4 2022.
  • Ken Griffin's portfolio value fell 2.4% quarter-over-quarter to $428B.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.